跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
TELFAST fexofenadine hydrochloride 180 mg tablet blister pack (unscheduled) - TGA Drug Approval Details
Approvals
/
TGA
/
TELFAST fexofenadine hydrochloride 180 mg tablet blister pack (unscheduled)
Approved
STANDARD
TELFAST fexofenadine hydrochloride 180 mg tablet blister pack (unscheduled)
Sanofi-Aventis Healthcare Pty Ltd T/A Sanofi Consumer Healthcare
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
92d2a8b8783334cb
Company
Sanofi-Aventis Healthcare Pty Ltd T/A Sanofi Consumer Healthcare
Type
Standard
Approval Details
Approval Id
92d2a8b8783334cb
Product Name
TELFAST fexofenadine hydrochloride 180 mg tablet blister pack (unscheduled)
Artg Id
342454
Artg Name
TELFAST fexofenadine hydrochloride 180 mg tablet blister pack (unscheduled)
Sponsor
Sanofi-Aventis Healthcare Pty Ltd T/A Sanofi Consumer Healthcare
Company Detail Path
/organization/sanofi-aventis-healthcare-pty-ltd
Artg Date
2020-08-26
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
92d2a8b8783334cb
Type
Standard
Back to TGA Approvals